Dose Finding Study in COPD

NCT00122434 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
389
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim